ABBV Jan 2025 110.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 04:08PM EDT. Market open.
Loading interactive chart…
- Investor's Business Daily
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
AbbVie stock has slumped 10% off its record high in March and is facing increasingly steep competition for its biggest moneymaker, Humira.
- Zacks
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.
© 2024 Yahoo. All rights reserved.